Faster answers for better outcomes
Rapid diagnostics are revolutionising the way that clinical decisions are made. Rapid diagnostic technology can yield better results for patients, healthcare providers, and the wider population when introduced in the right way. We can help you understand the options for implementing rapid diagnostics into current care pathways, and can quantify the costs, benefits and impact. This gives you the evidence to support better healthcare delivery.
Case Studies

The benefits and cost-savings of a new point-of-care test for chlamydia and gonorrhoea
We developed an understanding of how sexual health clinics in England could use a rapid point of care test for two common sexually transmitted infections. We defined the current patient care pathways and found that the pathways could be streamlined and costs of care reduced by using point-of-care tests. The economic model developed by Aquarius Population Health showed that the test could deliver £10 million in cost savings, and give far more effective management of chlamydia and gonorrhoea at a population level.
Publications

Cost-effectiveness and impact of five different point of care strategies to preserve last line treatment for gonorrhoea

Modelling the choice of high-risk human papillomavirus (HR-HPV) assay in the English cervical screening programme

Cost analysis of near patient chlamydia and gonorrhoea screening and treatment in further education/technical colleges

Cluster-randomised feasibility trial of a chlamydia test and treat (TnT) service in further education colleges

Assessing the impact of point-of-care testing for influenza and respiratory syncytial virus in children admitted to hospital

Rapid testing and treatment for sexually transmitted infections improve patient care and yield public health benefits

Cost-effectiveness of antimicrobial resistance point-of-care testing for optimising gonorrhoea treatment

Evaluating the costs, benefits and cost-effectiveness of multi-pathogen point-of-care tests for sexually transmitted infections

Modelling how point-of-care tests can enable personalised treatment for resistant gonorrhoea infections

Point-of-care tests for infectious diseases: Barriers to implementation across three London teaching hospitals
News









